Suhler, E. B., Jaffe, G. J., Nguyen, Q. D., Brezin, A. P., Zierhut, M., Vitale, A., … Dick, A. D. (2016). Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study. In ARTHRITIS & RHEUMATOLOGY (Vol. 68). WILEY.

Suhler, Eric B., Glenn J. Jaffe, Quan Dong Nguyen, Antoine P. Brezin, Manfred Zierhut, Albert Vitale, Mirjam van Velthoven, et al. “Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study.” In ARTHRITIS & RHEUMATOLOGY, Vol. 68. WILEY, 2016.

Suhler EB, Jaffe GJ, Nguyen QD, Brezin AP, Zierhut M, Vitale A, et al. Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study. In: ARTHRITIS & RHEUMATOLOGY. WILEY; 2016.

Suhler, Eric B., et al. “Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study.” ARTHRITIS & RHEUMATOLOGY, vol. 68, WILEY, 2016.

Suhler EB, Jaffe GJ, Nguyen QD, Brezin AP, Zierhut M, Vitale A, van Velthoven M, Adan A, Lim L, Kramer M, Schlaen A, Fortin E, Muccioli C, Goto H, Kaburaki T, Camez A, Song AP, Kron M, Tari S, Dick AD. Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study. ARTHRITIS & RHEUMATOLOGY. WILEY; 2016.